Position in NBIX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$674
New position
Shares Held
4
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#753
of 768 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Navigoe, LLC holds $21,203 across 13 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
171 | $12,288 | |
| 2 | HLN |
Haleon plc
|
233 | $2,173 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
150 | $2,173 | |
| 4 | VTRS |
Viatris Inc
|
82 | $1,302 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2 | $1,083 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
This page
|
4 | $674 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
27 | $664 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
3 | $332 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $674 | 4 | Shares | Sole | 2026-07-31 | |
| No filing history on record for this holder in this stock. | ||||||